Continuous fever monitoring in children getting cancer treatment
Part of Blood & lymphatic clinical trials.
This study tests a small wearable sensor that continuously tracks body temperature in children receiving cancer treatment. It may help detect fevers early, which is important because fevers can be a sign of serious infection during chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child must be between 1 month and 17 years old at the start of the study.
- The child must be receiving chemotherapy that is expected to last at least 2 months, or high-dose chemo followed by a stem cell transplant.
- There must be no skin condition on the wrist or arm that would prevent wearing a small sensor patch.
- You and/or the child must give written permission to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new arm-worn sensor called Thermodiag that measures body temperature continuously. It aims to see how accurate and safe it is for patients in intensive care, potentially replacing frequent manual temperature checks.
This study tests a wearable armband that continuously tracks your body temperature, using a small capsule you swallow that sends temperature data. It's a feasibility study to see if this approach works well for patients.
This trial tests whether a small home monitoring device can help keep children safer after chemotherapy, especially when they're at risk of a low white blood cell count (neutropenia). If your child is starting treatment, this device might help you catch early signs of infection and avoid complications.
This trial tests a wearable device that continuously measures your body temperature while you are in the hospital. It may help doctors track fever or temperature changes caused by infections or other illnesses.
This trial tests a smartphone app and wearable sensor to track your temperature after leaving the hospital, alerting you or your doctors if a fever develops. It aims to catch fevers early so you can get faster care.
This study tests a wearable device that continuously monitors your body temperature to detect cytokine release syndrome, a possible side effect of certain immunotherapies. The goal is to catch it early so you can get treatment faster.
Hear when a new Pediatric Oncology Patients With Risk for Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.